Shah, Khalid
Harvard Medical School,
United States
2025 Rank: 36,125
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1,075 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36,125 | 40,120 |
| Total Cites | 1,023 | 1,061 |
| H-index | 15 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 45 | 45 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 717 | 734 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 904 | 924 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
3.58%
|
|
Shah, Khalid
Harvard Medical School,
United States
2024 Rank: 41,598
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1,331 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41,598 | 43,263 |
| Total Cites | 869 | 940 |
| H-index | 14 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 22 | 23 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 40 | 42 |
| Number of Single+First+Last Authored Papers | 94 | 94 |
| Total Cites to Single+First+Last Authored Papers | 576 | 613 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 773 | 800 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.18 |
| Self-Citation Percentage |
7.55%
|
|
Shah, Khalid
Harvard Medical School,
United States
2023 Rank: 35,383
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1,238 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35,383 | 37,150 |
| Total Cites | 823 | 884 |
| H-index | 15 | 15 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 33 | 36 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 53 | 58 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 521 | 553 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 706 | 740 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.19 |
| Self-Citation Percentage |
6.90%
|
|
Shah, Khalid
Harvard Medical School,
United States
2022 Rank: 29,182
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1,081 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29,182 | 29,979 |
| Total Cites | 709 | 802 |
| H-index | 14 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 49 | 50 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 77 | 84 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 477 | 534 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 559 | 593 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.35 |
| Self-Citation Percentage |
11.60%
|
|
Shah, Khalid
Harvard Medical School,
United States
2021 Rank: 39,154
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 1,404 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39,154 | 38,183 |
| Total Cites | 793 | 925 |
| H-index | 16 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 61 | 67 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 99 | 115 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 548 | 643 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 627 | 668 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.38 |
| Self-Citation Percentage |
14.27%
|
|
Shah, Khalid
Harvard Medical School,
United States
2020 Rank: 59,906
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2,081 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59,906 | 59,418 |
| Total Cites | 462 | 526 |
| H-index | 10 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 42 | 44 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 79 | 83 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 324 | 367 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 369 | 391 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.35 |
| Self-Citation Percentage |
12.17%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.